Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Oct 18, 2011

Premium

Affymetrix last week launched its Axiom Genome-Wide Pan-African Array, which it claims offers genomic coverage of both common and rare alleles in populations of African ancestry, including West African, East African, and African American populations.

The array contains more than 2.2 million markers that are heterozygous in the African genome. It contains variants culled from the National Human Genome Research Institute's Catalog of Published Genome-Wide Association Studies, the Sanger Cancer Genome Census genes, major histocompatibilty complex genes, cardiovascular genes, and immune and inflammation pathway genes. The array also offers coverage across chromosomes X and Y, the mitochondrial genome, and drug metabolism genes.

According to the firm, the Axiom Pan-African Array offers about 90 percent coverage of HapMap Yoruba alleles with minor allele frequency greater than or equal to 2 percent. In addition, it has been validated in four African populations from the HapMap collection, including the Luhya from western Kenya; Maasai from eastern Kenya; Yoruba from Ibadan, Nigeria; and African ancestry in the Southwest US. In all cases, the Axiom Pan-African Array offers 15 percent to 20 percent more genomic coverage compared to other commercial arrays, the firm claims.

The array is designed to be used on the GeneTitan instrument with Axiom 2.0 Reagent Kits and Genotyping Console 4.1 for automated allele calling and quality control.

One customer is Rick Kittles, associate professor of medicine and director of the Institute of Human Genetics at the University of Illinois at Chicago. In a statement, he said that previous arrays on the market offered "poor genomic coverage" of African populations, an issue that has "significantly impacted our ability to understand the genetic factors that underlie the increased risk of African Americans for diseases such as cancer ... and cardiovascular and pulmonary disorders." Kittles said that his institute is currently using the Axiom Pan-African Array for prostate cancer, sickle-cell disease, and drug response research.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.